Registry of Hospitalized Patients Treated With Fondaparinux
1 other identifier
observational
220
0 countries
N/A
Brief Summary
Registry of Hospitalized patients at Brigham and Women's Hospital treated with Fondaparinux
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2007
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 24, 2007
CompletedFirst Posted
Study publicly available on registry
October 26, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedSeptember 17, 2009
September 1, 2009
1.9 years
October 24, 2007
September 15, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Venous Thromboembolism and Bleeding Events
90 Days
Secondary Outcomes (1)
Mortality
30 Days
Eligibility Criteria
BWH hospitalized patients receiving Fondaparinux
You may qualify if:
- BWH hospitalized patients receiving Fondaparinux
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel Z Goldhaber, MD
Brigham and Women's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 24, 2007
First Posted
October 26, 2007
Study Start
July 1, 2007
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
September 17, 2009
Record last verified: 2009-09